BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED...
84.4% of cancer patients taking ivermectin + mebendazole for 6 months reported either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
thefocalpoints.com